Pneumocystis jirovecii pneumonia following everolimus treatment of metastatic breast cancer

Everolimus is an inhibitor of mammalian target of rapamycin with anti-tumour activity. While everolimus is known to cause drug-induced pneumonitis, it is rarely associated with Pneumocystis jirovecii pneumonia (PJP). We report a patient on everolimus therapy for metastatic breast cancer that develop...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kuik, Kelvin Teck-Hong, Trubiano, Jason, Worth, Leon J., Harun, Nur-shirin, Steinfort, Daniel, Johnson, Douglas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4216328/
https://ncbi.nlm.nih.gov/pubmed/25379397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mmcr.2014.08.007
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller